Nigeria and Pakistan have signed trade agreements on affordable cardiovascular pharmaceuticals and other antibiotics at the ongoing trade exhibition by Pakistani companies in Lagos.
The agreements were signed on the last day of the 2nd Pakistan-Africa Trade Development Conference and Single Country Exhibition.
The Deputy Managing Director, Assene Laborex Eurapharma, Renaud Beauchamp, after signing the deal, told newsmen that quality cardiovascular drugs and antibiotics were important for effective treatment of diseases in Nigeria.
He said that the Memorandum of Understanding MoU between his firm and the Pakistani counterpart had offered Nigerian consumers access to quality and affordable pharmaceuticals.
Uti added that it would boost access to quality treatment of cardiovascular diseases in Nigeria.
The Pakistani counterpart, Muhammad Hashmi, said that Nigeria was a growing market for cardiovascular diseases and other chronic ailments hence the need for quality affordable medicine.
Hashmi said the price advantage would help curb prevalence of diseases like hypertension and stroke in Nigeria.
